One of the key objectives of the CBD is "the fair and equitable sharing of the benefits arising out of the utilisation of genetic resources’’."
Commercialisation* is a use that can generate tangible, financial benefits, but it requires very careful consideration. Not all material may be suitable for commercialisation. The first key step is to gain the prior informed consent (PIC) of the original provider or country of origin and to agree upon the process and how benefits will be shared. Depending on available resources and interest, you may wish to deal with commercial enquiries by directing them to contacts in the country of origin (such as the CBD National Focal Point, or an in-country botanic garden or research institution). Or you may choose to be actively involved in a commercialisation project with trusted partners in the country of origin and commercial sector. In general it is a good idea to include your position on commercialisation in your CBD policy.
*One useful definition of commercialisation, adopted by a number of botanic gardens, is ‘applying for, obtaining or transferring intellectual property rights or other tangible or intangible rights by sale or licence or in any other manner, commencement of product development, conducting market research, and seeking pre-market approval and/or the sale of any resulting product’ (from the Pilot Project for Botanic Gardens).